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Migraine affects about 12% of the population in Western
countries.1 Familial hemiplegic migraine (FHM) is the only
variety of migraine characterized by an autosomal
dominant pattern of inheritance and transient hemiparesis
followed by migraine headache.2 Some sporadic cases of
hemiplegic migraine with cerebellar signs have also been
r e p o r t e d .3 Sporadic hemiplegic migraine (SHM) has
clinical symptoms identical to FHM and distinct from
migraine with aura.4
CASE REPORT
A 20-year-old right-handed gentleman presented with a 2-
day history of left-sided weakness (evolving to maximum
deficit over half an hour), followed by severe unilateral
headache, vomiting and altered level of consciousness.
Weakness was preceded by numbness of the left half of
the body, and blurring of vision. There was no history of
fever, neckache, sphincter dysfunction, abnormal
movement, or head trauma. Over the last 8 years, the
patient had experienced several similar episodes of less
severe intensity, none lasting more than 4 hours.
Frequency was variable ranging from 2 per month to once
every 3-4 months. A brain CT scan and cerebrospinal fluid
examination done in 1993 were normal. Subsequent brain
CTs repeated CT at variable intervals were also normal. 
Pas t medical , surg ica l and family his tory  were
unremarkable. He was unmarried, a non-smoker and did
not consume alcohol. He had quit schooling after the 10th
grade because of his illness. Medication use included
multiple analgesics, including intravenous injections for
headache. 
On examination at the time of admission, he was opening
eyes on painful stimuli, localizing with the right hand, and
had no verbal response. Power was 0/5 in the left half of
the body with extensor plantar response on the left. He
had a left facial nerve palsy of upper motor neuron type.
He was moving the right side spontaneously, and there
were no signs of meningeal irritation. Fundi were normal.
Sensory, cerebellar, and gait examination were deferred. 
Routine blood tests including complete blood count, urea,
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ABSTRACT
Migraine is a common, chronic, incapacitating neurovascular disorder characterized by attacks of severe headache,
autonomic nervous system dysfunction and, in some patients, an aura involving neurological symptoms. Familial hemiplegic
migraine (FHM) is characterized by the presence of hemiparesis and occasionally even severe coma during attacks.
Sporadic hemiplegic migraine has also been described in the literature and has a clinical spectrum similar to FHM.
Figure 1: Left facial nerve palsy
creatinine, electrolytes, and random sugar were within
normal limits. Anti-epileptic drug levels were in the sub-
therapeutic range. Magnetic resonance imaging of the
brain (including diffusion-weighted studies) was normal. 
EEG showed severe right hemispheric dysfunction. The
patient's family did not consent to CSF analysis. There was
no signif icant cl inical improvement after 3 days of
hospitalization. An initial diagnosis of epilepsy (made in
the past at another facility) was questioned. On the basis
of a detailed history, exclusion of metabolic abnormalities,
and normal neuroimaging, a diagnosis of sporadic
hemiplegic migraine was tentatively made. 
He was started on NSAIDs, flunarizine and valproic acid.
Strength on the affected side gradually improved to 3/5,
he became fully conscious and oriented, and he was
discharged on above medications. After 3 days, he was
again hospitalized with severe headache, vomiting,
imbalance, and drowsiness. He was given steroids for
status migrainosus and intravenous verapamil (5 mg over
5 minutes), followed by oral verapamil (120 mg twice a
day). Within 48 hours his power returned to normal and
the headache subsided completely. Repeat EEG also
showed improvement. A final diagnosis of SHM was
reached. 
DISCUSSION
Migraine is characterized by episodes of headache that
are often throbbing, frequently unilateral, and may be
severe. In migraine without aura (previously known as
common migraine), attacks are usually associated with
nausea, vomiting, and sensitivity to l ight, sound or
movement. A combination of features is required for the
V O L .  1 ( 2 )   J U L - S E P  2 0 0 6P A K I S T A N  J O U R N A L  O F  N E U R O L O G I C A L  S C I E N C E S  76
Figure 2: Left-sided hemiparesis
Figure 3: T2-weighted MRI of the brain (normal study)
Figure 4: EEG showing right hemispheric dysfunction
Figure 5: Repeat EEG showing some improvement
diagnosis, though not all features are present in every
at tack or every patient. Any severe and recurrent
headache is most likely to be a form of migraine and to be
responsive to anti-migranous therapy. In 15% of patients,
migraine attacks are usually preceded or accompanied by
transient focal neurological symptoms; such patients have
migraine with aura (previously known as clas sic
migraine).5
Hemiplegic migraine was initially described in 1910 as a
type of  migraine consis ting of recurrent headache
associated with transient  hemipares is .6 F a m i l i a l
hemiplegic migraine (FHM) is a rare autosomal dominant
form of migraine with aura in which some degree of
hemiparesis is present during attacks. In FHM, the aura
typically lasts longer than in migraine with aura and
usually comprises visual, sensory, aphasic and motor
s y m p t o m s .7 However, patients with similar cl inical
symptoms but without other affected family members
have been reported, and the term sporadic hemiplegic
migraine has been used.8 Based on the literature, two
subforms of FHM families exist - pure FHM in 80% and
FHM fami lies with cerebel lar symptoms in 20%.9
Mutations in the gene  CACNA1A, which encodes a
neuronal calcium channel, are present in 50% families
with hemiplegic migraine including those with cerebellar
signs.2 Eight mutations in CACNA1A have been identified
in 18 families affected by hemiplegic migraine and two
patients with SHM.1 0 Genetic studies have revealed de
novo mutations or incomplete penetrance of CACNA1A in
patients with SHM.2 , 3 thereby suggesting that SHM may
be part of the spectrum of FHM syndromes.
FHM is a disorder with an interesting and complex
symptomatology. Motor aura symptoms are obligatory.
Furthermore, 69% have concurrence of basilar migraine,
with basilar-type symptoms during attacks. During
episodes, 95% patients always experience a headache,
4% experience headache in some attacks, and 1 % never
experience headache. Other associated symptoms include
cerebellar ataxia associated with progressive cerebellar
atrophy and epilepsy. FHM has a younger age of onset
compared with migraine with aura.9 
SHM has clinical symptoms identical to FHM. In SHM,
presence of motor aura symptoms is essential. Other
common aura symptoms are sensory (98%), visual (91%),
and some form of aphasia (81%). Up to 72% of patients
with SHM have concurrence of basilar migraine. Headache
almost always occurs in close temporal relation to the
aura, and SHM has an age aof onset younger than 45
y e a r s .4 The most differential diagnoses of SHM typically
includes epilepsy (post-ictal weakness following seizure, or
Todd's phenomenon), transient ischemic attack or stroke,
metabolic abnormalities associated with focal deficits
(hypercapnia, hypoglycemia, hyponatremia, hypocalcemia,
hepatic fai lure and renal fai lure), meningitis or
encephalitis, carotid dissection, anti-phospholipid antibody
syndrome, SLE, and orni thine transcarbamylase
deficiency. 
Inherited disorders associated with migraine headache
that may include hemiparesis include cerebral autosomal
dominant arteriopathy with subcortical infarcts and
leukoencephalopathy (CADASIL); mitochondrial myopathy,
encephalopathy, lactic acidosis and stroke like episodes
(MELAS); hereditary hemorrhagic telengiectesia (HHT);
hereditary cerebral amyloid angiopathy; familial cerebral
cavernous malformation; and benign familial infantile
convulsions.4
Current therapeutic recommendations are based on
isolated case repor ts and inc lude propranolo l,1 1
p h e n y t o i n ,1 2 f l u n a r i z i n e ,1 3 and verapamil.8 S u c c e s s f u l
responses of FHM to intravenous verapamil have been
r e p o r t e d .1 4 Verapamil, administered either orally or
intravenously, is also effective for SHM.15 Our patient had
no further episodes after starting oral verapamil 240 mg
daily, and was symptom-free at one-year follow up. SHM
is a relatively rare disorder which should be considered in
pat ients presenting wi th episodes of  reversible
neurological deficits with headaches; a therapeutic trial of
calcium channel blocker (verapamil) may be administered.
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